Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Change in Account Payables (2022 - 2023)

Historic Change in Account Payables for Bioadaptives (BDPT) over the last 2 years, with Q3 2023 value amounting to -$470.0.

  • Bioadaptives' Change in Account Payables changed N/A to -$470.0 in Q3 2023 from the same period last year, while for Mar 2024 it was -$470.0, marking a year-over-year change of. This contributed to the annual value of -$470.0 for FY2023, which is 12606.77% down from last year.
  • Latest data reveals that Bioadaptives reported Change in Account Payables of -$470.0 as of Q3 2023.
  • In the past 5 years, Bioadaptives' Change in Account Payables ranged from a high of $1803.0 in Q1 2022 and a low of -$470.0 during Q3 2023